Navigation Links
Endo Pharmaceuticals Completes Next Step in Regulatory Process for FORTESTA™ for Men With Low Testosterone
Date:7/1/2010

ipeline products; competition for the business of our branded and generic products, and in connection with our acquisition of rights to intellectual property assets; market acceptance of our future products; government regulation of the pharmaceutical industry; our dependence on a small number of products; our dependence on outside manufacturers for the manufacture of a majority of our products; our dependence on third parties to supply raw materials and to provide services for certain core aspects of our business; new regulatory action or lawsuits relating to our use of narcotics in most of our core products; our exposure to product liability claims and product recalls and the possibility that we may not be able to adequately insure ourselves; the successful efforts of manufacturers of branded pharmaceuticals to use litigation and legislative and regulatory efforts to limit the use of generics and certain other products; our ability to successfully implement our acquisition and in-licensing strategy; regulatory or other limits on the availability of controlled substances that constitute the active ingredients of some of our products and products in development; the availability of third-party reimbursement for our products; the outcome of any pending or future litigation or claims by third parties or the government, and the performance of indemnitors with respect to claims for which we have been indemnified; our dependence on sales to a limited number of large pharmacy chains and wholesale drug distributors for a large portion of our total revenues; a determination by a regulatory agency that we are engaging or have engaged in inappropriate sales or marketing activities, including promoting the "off-label" use of our products and other risks and uncertainties, including those detailed from time to time in our periodic reports filed with the Securities and Exchange Commission, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual repor
'/>"/>
SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... July 3, 2015 According ... & Cardiac Rhythm Management Market ECG, Implantable Loop ... Implantable Cardioverter Defibrillator, Dual Chamber Pacemaker, CRT-D, CRT-P ... the global Cardiac Monitoring (CM) and Cardiac Rhythm ... $26,646.5 Million by 2020 from $21,137.7 Million in ...
(Date:7/3/2015)... , July 3, 2015 A ... of hypertension, diabetes and thyroid disorders in ... and a major conference dedicated to these diseases. ... Diabetes Online , Manage Hypertension Online and ... operated by EXCEMED - combine the world,s ...
(Date:7/3/2015)... July 3, 2015  Obsidian HDS, the developer of ... service for the management of data on pharmaceutical and ... PharmaShine now includes the 2014 Open Payments General and ... on June 30. The data disclosed on Open Payments ... industry and providers totaling $6.49 billion and is the ...
Breaking Medicine Technology:Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4Combating Three Major Chronic Diseases in Latin America With Medical Education 2New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2
... WAUKESHA, Wis., Sept. 29 MedPro Imaging, a premier ... of its Ultrasound Transducer Repair Division.  Based on proprietary ... MedPro Imaging will offer high quality computer-based transducer repair ... industry on probe exchange programs. "The industry ...
... 29 Crosstex International, a subsidiary of ... today the publication of sponsored research that suggests a ... commonly referred to as surgical masks, than previously understood. ... mask or respirator is most effective when worn by ...
Cached Medicine Technology:MedPro Imaging Launches Ultrasound Transducer Repair Division 2New Mask Study Supports CDC's Updated Guidance for Seasonal Flu Prevention Strategies 2New Mask Study Supports CDC's Updated Guidance for Seasonal Flu Prevention Strategies 3
(Date:7/3/2015)... (PRWEB) , ... July 04, 2015 , ... The Harvest Hope Food Bank ... July. Four local AlignLife offices in the area of Greenville SC are making ... to be made by patients only. They are asking for donations from the public as ...
(Date:7/3/2015)... ... ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. Rod J. ... To be held from March 4th - 6th, the 2016 (a previous announcement had ... , Designed to take participants from the basic training and fundamentals of nasal surgery ...
(Date:7/3/2015)... ... 03, 2015 , ... Talcum powder attorneys representing clients in national lawsuits announce ... Lawsuit Center website. Just as the previous version did, the new website will serve ... updates and ovarian cancer warning information. The site is routinely updated with news articles ...
(Date:7/3/2015)... , ... July 03, 2015 , ... Every year, One-to-1 ... Train-a-Thon where they provide members of the Red Deer community with free fitness training ... of fitness training, games, food, events and entertainment raised thousands of charity dollars and ...
(Date:7/2/2015)... ... ... Following the recent report by JAMA Internal Medicine published on June 22, ... emphatically declared a war on obesity in the United States. , "Obesity is one ... the magnitude of this discovery. For that reason, I am declaring, along with my ...
Breaking Medicine News(10 mins):Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4
... launched its approved generic formulation of clarithromycin// immediate ... press release. Ranbaxy has been given the green ... and 500 mg under the Ranbaxy label. Clarithromycin ... to moderate infections caused by susceptible strains of ...
... of California-San Francisco has published that weight loss// supplements ... increasing heart beat rate and blood pressure. It ... ,The study spearheaded by Dr. Christine A. Haller ... group of 16 healthy adults. Two tests were performed ...
... mutation of the gene involved in causing// the condition ... from Yale School of Medicine have reported in their ... for sodium channel Nav1.7 is responsible for people to ... have studied the DNA samples from 36 members of ...
... smoking during pregnancy is associated with reduced birthweight// and ... associated with several problems in the newborn. ... and spouses' expired air carbon monoxide (CO) concentrations (EACO) ... monoxide (CO) concentrations (EACO) is a measure of smoking ...
... Mannheim, concludes that women appear to develop alcoholic brain damage ... become dependant on alcohol not as frequently as men do. ... general alcohol consumption pattern if men and women. Therefore it ... pregnancy. It might have adverse effects on the child as ...
... Lorenzos oil can prevent the spread of a form of ... from Kennedy Krieger Institute in Baltimore have reported that use ... X-ALD in boys aged 7 years and younger who were ... doses of the oil, which is a composite mixture of ...
Cached Medicine News:
Rhoton Curettes, titanium, length 191 mm, straight....
Temporary...
Barraquer needle holder, curved, delicate....
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Medicine Products: